Tamar Grossman, based in San Diego, CA, US, is currently a Vice President, Global head of RNA, Gene Therapy and Delivery at Johnson & Johnson Innovative Medicine, bringing experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, Landes Bioscience Journal and Johnson & Johnson Innovative Medicine. Tamar Grossman holds a PhD in Biochemistry, Electrophysiology, Genetics, Molecular biology @ Tel Aviv University. With a robust skill set that includes Genetics, Biochemistry, Cell Biology, In Vivo, Animal Models and more, Tamar Grossman contributes valuable insights to the industry. Tamar Grossman has 2 emails and 1 mobile phone number on RocketReach.